Cancer Research Donn Young Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Cancer Research 68, 2773, April 15, 2008. doi: 10.1158/0008-5472.CAN-07-6754
© 2008 American Association for Cancer Research
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Medina, R.
Right arrow Articles by Stein, G. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Medina, R.
Right arrow Articles by Stein, G. S.

Cell, Tumor, and Stem Cell Biology

MicroRNAs 221 and 222 Bypass Quiescence and Compromise Cell Survival

Ricardo Medina1, Sayyed K. Zaidi1, Chang-Gong Liu2, Janet L. Stein1, Andre J. vanWijnen1, Carlo M. Croce2 and Gary S. Stein1

1 Department of Cell Biology and Cancer Center, University of Massachusetts Medical School, Worcester, Massachusetts and 2 Department of Molecular Virology, Immunology and Medical Genetics and Comprehensive Cancer Center, Ohio State University, Columbus, Ohio

Requests for reprints: Gary S. Stein, Department of Cell Biology and Cancer Center, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01655. Phone: 508-856-5625; Fax: 508-856-6800; E-mail: gary.stein{at}umassmed.edu.

Key Words: cell cycle • miRNA • miR-221 • miR-222 • p27/Kip1 • p57/Kip2 • T98G glioblastoma

MicroRNAs (miRNA) have tumor suppressive and oncogenic potential in human cancer, but whether and how miRNAs control cell cycle progression is not understood. To address this question, we carried out a comprehensive analysis of miRNA expression during serum stimulation of quiescent human cells. Time course analyses revealed that four miRNAs are up-regulated and >100 miRNAs are down-regulated, as cells progress beyond the G1-S phase transition. We analyzed the function of two up-regulated miRNAs (miR-221 and miR-222) that are both predicted to target the cell growth suppressive cyclin-dependent kinase inhibitors p27 and p57. Our results show that miR-221 and miR-222 both directly target the 3' untranslated regions of p27 and p57 mRNAs to reduce reporter gene expression, as well as diminish p27 and p57 protein levels. Functional studies show that miR-221 and miR-222 prevent quiescence when elevated during growth factor deprivation and induce precocious S-phase entry, thereby triggering cell death. Thus, the physiologic up-regulation of miR-221 and miR-222 is tightly linked to a cell cycle checkpoint that ensures cell survival by coordinating competency for initiation of S phase with growth factor signaling pathways that stimulate cell proliferation. [Cancer Res 2008;68(8):2773–80]




This article has been cited by other articles:


Home page
 EndocrinologyHome page
K. Qian, L. Hu, H. Chen, H. Li, N. Liu, Y. Li, J. Ai, G. Zhu, Z. Tang, and H. Zhang
Hsa-miR-222 Is Involved in Differentiation of Endometrial Stromal Cells in Vitro
Endocrinology, October 1, 2009; 150(10): 4734 - 4743.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
E. M. C. Ohlsson Teague, C. G. Print, and M. L. Hull
The role of microRNAs in endometriosis and associated reproductive conditions
Hum. Reprod. Update, September 22, 2009; (2009) dmp034v1.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
L. Gramantieri, F. Fornari, M. Ferracin, A. Veronese, S. Sabbioni, G. A. Calin, G. L. Grazi, C. M. Croce, L. Bolondi, and M. Negrini
MicroRNA-221 Targets Bmf in Hepatocellular Carcinoma and Correlates with Tumor Multifocality
Clin. Cancer Res., August 15, 2009; 15(16): 5073 - 5081.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
R. Ueda, G. Kohanbash, K. Sasaki, M. Fujita, X. Zhu, E. R. Kastenhuber, H. A. McDonald, D. M. Potter, R. L. Hamilton, M. T. Lotze, et al.
Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by down-regulation of ICAM-1
PNAS, June 30, 2009; 106(26): 10746 - 10751.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. J. O'Hara, L. Wang, B. J. Dezube, W. J. Harrington Jr, B. Damania, and D. P. Dittmer
Tumor suppressor microRNAs are underrepresented in primary effusion lymphoma and Kaposi sarcoma
Blood, June 4, 2009; 113(23): 5938 - 5941.
[Abstract] [Full Text] [PDF]

Home page
 J. Gen. Virol.Home page
L. S. Lambeth, Y. Yao, L. P. Smith, Y. Zhao, and V. Nair
MicroRNAs 221 and 222 target p27Kip1 in Marek's disease virus-transformed tumour cell line MSB-1
J. Gen. Virol., May 1, 2009; 90(5): 1164 - 1171.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. Sun, Q. Wang, S. Balk, M. Brown, G.-S. M. Lee, and P. Kantoff
The Role of microRNA-221 and microRNA-222 in Androgen-Independent Prostate Cancer Cell Lines
Cancer Res., April 15, 2009; 69(8): 3356 - 3363.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
Y.-K. Kim, J. Yu, T. S. Han, S.-Y. Park, B. Namkoong, D. H. Kim, K. Hur, M.-W. Yoo, H.-J. Lee, H.-K. Yang, et al.
Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer
Nucleic Acids Res., April 1, 2009; 37(5): 1672 - 1681.
[Abstract] [Full Text] [PDF]

Home page
 J ANIM SCIHome page
M. Z. Carletti and L. K. Christenson
MicroRNA in the ovary and female reproductive tract
J Anim Sci, April 1, 2009; 87(14_suppl): E29 - E38.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
X. Liu, Y. Cheng, S. Zhang, Y. Lin, J. Yang, and C. Zhang
A Necessary Role of miR-221 and miR-222 in Vascular Smooth Muscle Cell Proliferation and Neointimal Hyperplasia
Circ. Res., February 27, 2009; 104(4): 476 - 487.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
Y. Zeng
Regulation of the Mammalian Nervous System by MicroRNAs
Mol. Pharmacol., February 1, 2009; 75(2): 259 - 264.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. Van Laere, T. Beissbarth, I. Van der Auwera, G. Van den Eynden, X. B. Trinh, H. Elst, P. Van Hummelen, P. van Dam, E. Van Marck, P. Vermeulen, et al.
Relapse-Free Survival in Breast Cancer Patients Is Associated with a Gene Expression Signature Characteristic for Inflammatory Breast Cancer
Clin. Cancer Res., November 15, 2008; 14(22): 7452 - 7460.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J.-J. Zhao, J. Lin, H. Yang, W. Kong, L. He, X. Ma, D. Coppola, and J. Q. Cheng
MicroRNA-221/222 Negatively Regulates Estrogen Receptor{alpha} and Is Associated with Tamoxifen Resistance in Breast Cancer
J. Biol. Chem., November 7, 2008; 283(45): 31079 - 31086.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. E. Miller, K. Ghoshal, B. Ramaswamy, S. Roy, J. Datta, C. L. Shapiro, S. Jacob, and S. Majumder
MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1
J. Biol. Chem., October 31, 2008; 283(44): 29897 - 29903.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2008 by the American Association for Cancer Research.